Through ground-breaking research, scientists have discovered what they believe will lead to relief for addicts through the development of medications able to decrease the risk of relapse, and improve the addict's chances for recovery from this powerfully addictive drug. The breakthrough project used rats in the trials, and enabled lead investigator Marina E. Wolf, Ph.D., who is Professor and Chair of Neuroscience at the Rosalind Franklin University of Medicine and Science in North Chicago, to determine that after prolonged periods of forced abstinence from cocaine self-administration there was a marked increase in the number, and a distinct change in the composition, of newly formed proteins, called AMPA glutamate receptors, in the area of the brain that is known to be responsible for a person's feelings of motivation and reward.
She and her investigators noted that the new, and more plentiful, receptors were actually providing stronger stimulation to that part of the brain than normal receptors do. Because of their number and the area of the brain they were active in, they, in effect, were causing a sort of rebirth and, in fact, an intensification of those cocaine-related cues; those cocaine related memories of people, places and things that are found to haunt the reformed addict long after abstinence from the drug.
Dr. Wolf and her investigators were able to block these receptors and were able to substantially decrease the intensified cue-induced drug craving in the rat model. This is what leads the scientists to the belief that medications can be developed to block the same receptors, and thus the continuing drug cravings, in humans without interfering with the normal AMPA receptors, which are important for normal brain functions such as learning and memory.
This research was supported by the National Institute on Drug Abuse which is part of the National Institutes of Health, and was published in the May 25, 2008 issue of the journal Nature.
By Jody Cross